Crystal and Molecular Structure of N-[2-(6-Methoxy-2-oxo-2H-Chromen-4-yl-Benzofuran-3-yl]- Benzamide


The crystal structure of the potential active N-[2-(6-Methoxy-2-oxo-2H-chromen-4-yl)-benzofuran-3-yl]-benzamide (C25H17NO5) (I) has been determined from single crystal X-ray diffraction data. The title compound crystallizes in the monoclinic space group P 21/n, with a = 12.0551(11), b = 9.7853(8), c = 16.6517(16) , β = 90.092(4)o, V = 1964.28(3) 3, Dcalc = 1.391 Mg/m3, Z = 4. In the structure, intermolecular H-bonds lead to the formation of a centrosymmetric dimer of the molecule. There is an intramolecular C7—H7…N1 hydrogen bond forming a closed seven membered ring. There are also intramolecular π-π interactions presented between the 3,6-Dihydro-2H-pyran ring of the chromen moiety [Cg2…Cg2 distance = 3.5812(13) ]. The packing structure is stabilized by these C—H…N, N—H…O hydrogen bonds, C—H… π and π…π interactions.

Share and Cite:

G. Anuradha, G. Vasuki, I. Khan and M. Kulkarni, "Crystal and Molecular Structure of N-[2-(6-Methoxy-2-oxo-2H-Chromen-4-yl-Benzofuran-3-yl]- Benzamide," Crystal Structure Theory and Applications, Vol. 1 No. 3, 2012, pp. 107-113. doi: 10.4236/csta.2012.13020.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] V. Z. Rodrigues, B. T. Gowda, V. Vrábel and J. Ko?í?ek, “4-Chloro-N-(3,5-Dimethylphenyl)Benzamide,” Acta Crystallographica E, Vol. 68, Part 3, 2012, p. o820. doi:10.1107/S1600536812007180
[2] V. Maddi, S. N. Mamledesai, D. Satyanarayana and S. Swamy, “Synthesis and Antiinflammatory Activity of Substituted (2-Oxochromen-3-yl)Benzamides,” Indian Journal of Pharamceutical Sciences, Vol. 69, No. 6, 2007, pp. 847-849. doi:10.4103/0250-474X.39452
[3] L. Muruganandam, S. Rajeswari, D. Tamilvendan, V. Ramkumar and G. V. Prabhu, “N-[Morpholino(phenyl)methyl] benzamide,” Acta Crystallographica E, Vol. 65, Part 3, 2009, p. o578. doi:10.1107/S1600536809005327
[4] Anuradha Gurumoorthy, Vasuki Gopalsamy, K. Ramamurthi, Poonam Piplani and Ruchi Malik, “N-[4-(2-Morpholinoethoxy)Phenyl] Acetamide Monohydrate,” Acta Crystllographica E, Vol. 67, Part 2, 2011, p. o262. doi:10.1107/S1600536810053675
[5] A. Saeed, S. Hussain and M. Bolte, “N-(2-MethoxyPhenyl)-2-Nitrobenzamide,” Acta Crystallographica E, Vol. 64, Part 12, 2008, p. o521. doi:10.1107/S1600536808002298
[6] A. Saeed, R. A. Khera, N. Abbas, J. Simpson and R. G. Stanley, “N-Butyl-4-Chlorobenzamide,” Acta Crystallographica E, Vol. 64, Part 12, 2008, pp. o2322-o2323. doi:10.1107/S1600536808036313
[7] Bruker, “APEX2 and SAINT-Plus,” Bruker AXS Inc., Madison, 2004.
[8] G. M. Sheldrick, “SHELXS-97 and SHELXL-97, Program for Crystal Structure Solution and Refinement,” University of Gottingen, Gottingen, 1997.
[9] G. M. Sheldrick, “A Short History of SHELX,” Acta Crystallographica A, Vol. 64, Part 1, 2008, pp. 112-122. doi:10.1107/S0108767307043930
[10] L. J. Farrugia, “ORTEP-3 for Windows—A Version of ORTEP-III with a Graphical User Interface (GUI),” Journal of Applied Crystallography, Vol. 30, No. 1, 1997, p. 565. doi:10.1107/S0021889897003117
[11] A. L. Spek, “Structure Validation in Chemical Crystallography,” Acta Crystallographica D, Vol. 65, Part 2, 2009, pp. 148-155. doi:10.1107/S090744490804362X
[12] L. J. Farrugia, “WinGX Suite for Small-Molecule Single-Crystal Crystallography,” Journal of Applied Crystallography, Vol. 32, Part 4, 1999, pp. 837-838. doi:10.1107/S0021889899006020
[13] Neerja Gupta and Ruby Naaz, International Journal of Pharma and Bio Sciences, Vol. 1, No. 3, 2010, pp. 1-7.
[14] M. D. Ghate, M. V. Kulkarni, R. Shobha and S. Y. Kattimani, “Synthesis of Vanillin Ethers from 4-(Bromomethyl) Coumarins as Anti-Inflammatory Agents,” European Journal of Medicinal Chemistry, Vol. 38, No. 3, 2003, pp. 297-302. doi:10.1016/S0223-5234(03)00016-3

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.